Neuroprotection in Schizophrenia and Its Therapeutic Implications
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yong-Ku | - |
dc.contributor.author | Na, Kyoung-Sae | - |
dc.date.available | 2020-02-27T18:41:04Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2017-07 | - |
dc.identifier.issn | 1738-3684 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/5941 | - |
dc.description.abstract | Schizophrenia is a chronic and debilitating mental disorder. The persisting negative and cognitive symptoms that are unresponsive to pharmacotherapy reveal the impairment of neuroprotective aspects of schizophrenia. In this review, of the several neuroprotective factors, we mainly focused on neuroinflammation, neurogenesis, and oxidative stress. We conducted a narrative and selective review. Neuroinflammation is mainly mediated by pro-inflammatory cytokines and microglia. Unlike peripheral inflammatory responses, neuroinflammation has a role in various neuronal activities such as neurotransmission neurogenesis. The cross-talk between neuroinflammation and neurogenesis usually has beneficial effects in the CNS under physiological conditions. However, uncontrolled and chronic neuroinflammation exert detrimental effects such as neuronal loss, inhibited neurogenesis, and excessive oxidative stress. Neurogenesis is also a major component of neuroprotection. Adult neurogenesis mainly occurs in the hippocampal region, which has an important role in memory formation and processing. Impaired neurogenesis and an ineffective response to antipsychotics may be thought to indicate a deteriorating course of schizophrenia. Oxidative stress and excessive dopaminergic neurotransmission may create a vicious cycle and consequently disturb NMDA receptor-mediated glutamatergic neurotransmission. Based on the current evidences, several neuroprotective therapeutic approaches have been reported to be efficacious for improving psychopathology, but further longitudinal and large-sample based studies are needed. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN NEUROPSYCHIATRIC ASSOC | - |
dc.relation.isPartOf | PSYCHIATRY INVESTIGATION | - |
dc.subject | TUMOR-NECROSIS-FACTOR | - |
dc.subject | PLACEBO-CONTROLLED TRIAL | - |
dc.subject | LEUKEMIA INHIBITORY FACTOR | - |
dc.subject | ADULT HIPPOCAMPAL NEUROGENESIS | - |
dc.subject | CENTRAL-NERVOUS-SYSTEM | - |
dc.subject | INDUCED MICROGLIAL ACTIVATION | - |
dc.subject | WORKING-MEMORY DYSFUNCTION | - |
dc.subject | N-ACETYL-CYSTEINE | - |
dc.subject | SUPEROXIDE-DISMUTASE | - |
dc.subject | LIPID-PEROXIDATION | - |
dc.title | Neuroprotection in Schizophrenia and Its Therapeutic Implications | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000405767400001 | - |
dc.identifier.doi | 10.4306/pi.2017.14.4.383 | - |
dc.identifier.bibliographicCitation | PSYCHIATRY INVESTIGATION, v.14, no.4, pp.383 - 391 | - |
dc.identifier.kciid | ART002247034 | - |
dc.identifier.scopusid | 2-s2.0-85026302158 | - |
dc.citation.endPage | 391 | - |
dc.citation.startPage | 383 | - |
dc.citation.title | PSYCHIATRY INVESTIGATION | - |
dc.citation.volume | 14 | - |
dc.citation.number | 4 | - |
dc.contributor.affiliatedAuthor | Na, Kyoung-Sae | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Neuroprotection | - |
dc.subject.keywordAuthor | Neuroinflammation | - |
dc.subject.keywordAuthor | Cytokine | - |
dc.subject.keywordAuthor | Neurogenesis | - |
dc.subject.keywordAuthor | Schizophrenia | - |
dc.subject.keywordPlus | TUMOR-NECROSIS-FACTOR | - |
dc.subject.keywordPlus | PLACEBO-CONTROLLED TRIAL | - |
dc.subject.keywordPlus | LEUKEMIA INHIBITORY FACTOR | - |
dc.subject.keywordPlus | ADULT HIPPOCAMPAL NEUROGENESIS | - |
dc.subject.keywordPlus | CENTRAL-NERVOUS-SYSTEM | - |
dc.subject.keywordPlus | INDUCED MICROGLIAL ACTIVATION | - |
dc.subject.keywordPlus | WORKING-MEMORY DYSFUNCTION | - |
dc.subject.keywordPlus | N-ACETYL-CYSTEINE | - |
dc.subject.keywordPlus | SUPEROXIDE-DISMUTASE | - |
dc.subject.keywordPlus | LIPID-PEROXIDATION | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.